Volume 8, Number 11—November 2002
Tuberculosis Genotyping Network, United States
Cross-Jurisdictional Transmission of Mycobacterium tuberculosis in Maryland and Washington, D.C., 1996–2000, Linked to the Homeless
From 1996 to 2000, 23 Maryland and Washington, D.C., tuberculosis cases were identified in one six-band DNA cluster. Cases were clustered on the basis of their Mycobacterium tuberculosis isolates. Medical record reviews and interviews were conducted to identify epidemiologic linkages. Eighteen (78%) of the 23 case-patients with identical restriction fragment length polymorphism patterns were linked to another member; half the patients were associated with a Washington, D.C., homeless shelter. Molecular epidemiology defined the extent of this large, cross-jurisdictional outbreak.
A rise in homelessness in particular and poverty in general partially accounted for the resurgence of tuberculosis (TB) in the United States from 1984 to 1992 (1,2). In Maryland, as part of the National Tuberculosis Genotyping and Surveillance Network activities, population-based DNA fingerprinting of Mycobacterium tuberculosis isolates from culture-positive patients was conducted from January 1996 through December 2000. Selected Washington, D.C., isolates from TB patients with suspected or known homelessness were DNA fingerprinted as early as 1996. The Washington, D.C. TB Control staff determined suspected or known homelessness from information contained in case histories and medical records. An interjurisdictional investigation was conducted among homeless persons in Washington, D.C., and Maryland to establish epidemiologic linkages.
Standard methods were used for IS6110 restriction fragment length polymorphism (RFLP) analysis of M. tuberculosis isolates (3). A cluster was defined as a group of two or more cases with a matching DNA fingerprint pattern (+/-1 band). Spoligotyping (secondary typing) was performed on all clustered strains having six or fewer copies of IS6110 (4). Medical record reviews and interviews were conducted for all clustered cases to identify connections. We used chi-square and Fisher exact tests to compare demographic and clinical characteristics between the homeless and nonhomeless groups.
A homeless person was defined, at the time a case was reported to the health department, as a person who lacked a fixed, regular, and adequate nighttime residence within the past year or a person who gave a history of homelessness in the recent past (1–5 years). Alcoholism and drug use were routinely documented on the TB case report form. Alcohol abuse was defined as patient-reported alcoholism or disclosure of excessive alcohol use. Recent drug use was defined as injecting or noninjecting drug use within the past year.
From January 1996 through December 2000, nearly all (99 % or 1,181/1,191) of the culture-positive isolates from Maryland were DNA fingerprinted. Since the District of Columbia was not a network sentinel site in the genotyping network, only 29 (9%) of the 318 M. tuberculosis isolates from culture-positive Washington, D.C., cases were fingerprinted (only those for outbreak investigations). Maryland Cluster A6 (Centers for Disease Control and Prevention [CDC] designations 00104 and 00645) consisted of 23 case isolates; 15 (65%) A6 case-patients were residents of Maryland, and the remaining 8 (35%) were District of Columbia residents. Spoligotypes (CDC designation 3) were identical for all 23 isolates. The first known case in Cluster A6 was reported in March 1996; 22 subsequent cases occurred through November 2000 (Figure). All patients were born in the United States and were African Americans. Homelessness was documented for 14 (61%) of the 23 patients. Eighty-seven percent had acid-fast bacilli smear-positive sputum, and 52% had pulmonary, cavitary disease. Other TB risk factors included alcohol abuse (52%), HIV infection (39%), and drug use (22%). Nonhomeless persons differed from homeless persons because they were more likely to be women (p<0.02) and were less likely to have identified risk behaviors. Nonhomeless patients were similar to the homeless in the proportion of cases with pulmonary cavities (Table).
Most cases (78% or 18/23) in Cluster A6 had epidemiologic connections. Nine (50%) of the connected case-patients were directly linked to a large homeless shelter in Washington, D.C. Six case-patients were connected by time and place on the basis of histories of homelessness, socializing with homeless persons, caring for a homeless patient, and sharing boarding or transitional houses. The remaining three were rural nonhomeless case-patients connected by workplace and social links (e.g., drinking); however, they had no other known links with other cluster members. More than one third of the relationships were identified only after the DNA cluster investigation.
In late 1998, active disease caused by the same strain was diagnosed in a nurse who had cared for two hospitalized persons (cluster case-patients), a nonhomeless Maryland resident in 1997 and a homeless Washington, D.C., resident in 1998. Both hospitalized persons were highly infectious with sputum smear-positive and cavitary disease. The nurse cared for the first patient before the patient’s diagnosis and subsequent isolation and cared for the second patient only during isolation. Because the second patient reportedly often removed his mask and left his isolation room, we could not determine definitively which case-patient was the source of the nurse’s infection.
Our molecular epidemiology study identified TB transmission between homeless and nonhomeless settings in Maryland and provided an opportunity to assess transmission between the state and adjacent Washington, D.C. Population-based molecular epidemiologic studies consistently demonstrate that TB transmission is geographically localized in one or two adjoining jurisdictions (5–8). We are aware of only two DNA-confirmed instances of TB transmission between states (9,10). Interestingly, the Cluster A6 strain exactly matched that seen in a large outbreak among the homeless in Syracuse, New York (J Driscoll, pers. comm.) (11). The Syracuse outbreak began with a single, highly infectious case that was reported in 1992. We do not know when this strain appeared in Maryland because statewide genotyping was not available in our area before 1996. Further investigation and consultation with Syracuse health department staff showed no additional epidemiologic links between the two states.
The Cluster A6 strain was not identified in isolates analyzed in two other sentinel sites in the TB genotyping network (Massachusetts and New Jersey) or more recently in New York City homeless or nonhomeless outbreaks (J. Driscoll, pers. commun.). This observation suggests that the existing links may not be among immediate neighbors but may be more far-reaching. As disease incidence continues to decline and programs consolidate into regional offices (12), the expanded use of molecular epidemiology will prove increasingly valuable in TB investigations.
Even with expanded (or regional) genotyping of isolates, an active relationship between jurisdictions remains essential to prevent transmission or progression to active disease in patients and their contacts within a region. To investigate Cluster A6, Maryland and Washington, D.C., TB control staff held frequent meetings and teleconferences to review data on RFLP patterns, case characteristics and locations, and contact information. Local health department personnel in Washington, D.C., and adjacent Maryland counties routinely share contact data on as many as half of their cases (TB Programs, Washington, D.C., and Maryland, unpub. data, 2002).
Whether the Cluster A6 strain was introduced recently or was a result of prior TB in the Washington, D.C., homeless population is not unknown. The underlying tuberculin skin-test (TST) positivity was unknown for most case-patients, and only one person had a documented TST conversion. However, persons at high risk for TB, particularly those who were homeless or had HIV infection, are at increased risk for exogenous reinfection (13,14). Homelessness, along with other TB risk factors, can make treatment a daunting task.
Cases reported in 2000 indicate that this large outbreak was not controlled effectively (Figure). Three cases with this strain were also reported in 2001—the most recent in October. The ongoing appearance of patients indicates that TB in the homeless continues to be a challenge in the region. Although 78% of the case connections were found in this difficult-to-reach population, one third of these linkages were identified only after DNA fingerprinting of the M. tuberculosis isolates. More thorough contact investigations would not likely have established connections. Cofactors such as substance abuse, mental illness, and HIV infection further complicate the likelihood of obtaining reliable histories and contact reports. Although Cluster A may have eventually been traced to the homeless shelter, the magnitude of the outbreak might have never been realized without the inclusion of District of Columbia cases in our DNA fingerprinting sample (regionalization). Universal M. tuberculosis genotyping in Washington, D.C., would likely have shown additional cases clustered among the homeless and nonhomeless and further defined the extent of the outbreak.
Molecular epidemiology showed unsuspected TB transmission across jurisdictional borders and transmission involving the homeless and the nonhomeless populations. Investigation of this large interjurisdictional cluster required close collaboration between the Maryland and Washington, D.C., TB Control Programs. As disease incidence continues to decline, regionalizing program efforts with associated M. tuberculosis genotyping will be essential to detect and prevent ongoing disease transmission, particularly in difficult-to-reach populations.
Ms. Lathan, MPH, is a health science analyst for the American Public Health Association. At the time of this study, she was an epidemiologist with the Maryland Department of Health and Mental Hygiene, Division of Tuberculosis Control, Refugee and Migrant Health. As such, she coordinated interviews and medical record reviews of case-patients with DNA matching strains and investigated a number of tuberculosis outbreaks.
We thank Margaret Tipple and the staff of the Washington, D.C., Department of Health Tuberculosis (TB) Control Program, and Thomas Walsh and the staff of Montgomery and Prince George’s County TB Programs.
Funding for this project was provided by the Centers for Disease Control and Prevention, Cooperative Agreement for the National Tuberculosis Genotyping and Surveillance Network study.
- Brudney K, Dobkin J. Resurgent tuberculosis in New York City. Human immunodeficiency virus, homelessness, and the decline of tuberculosis control programs. Am Rev Respir Dis. 1991;144:745–9.
- Centers for Disease Control and Prevention. Prevention and control of tuberculosis among homeless persons. Recommendations of the advisory council for the elimination of tuberculosis. MMWR Morb Mortal Wkly Rep. 1992;41:RR-5.
- Van Embden JDA, Cave MD, Crawford JT, Dale JW, Eisenach KD, Gicquel B, Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology. J Clin Microbiol. 1993;31:406–9.
- Kamerbeek J, Schouls L, Kolk A, van Agterveld M, van Sooligen D, Kuijper S, Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology. J Clin Microbiol. 1997;35:907–14.
- Cronin WA, Golub JE, Magder LS, Baruch NG, Lathan MJ, Mukasa LN, Usefulness of spoligotyping for secondary typing of Mycobacterium tuberculosis isolates with low copy numbers of IS6110. J Clin Microbiol. 2001;39:3709–11.
- Kline SE, Hedemark LL, Davies SF. Outbreak of tuberculosis among regular patrons of a neighborhood bar. N Engl J Med. 1995;333:222–7.
- Bishai WR, Graham NMH, Harrington S, Pope DS, Hooper N, Astemborski J, Molecular and geographic patterns of tuberculosis transmission after 15 years of directly observed therapy. JAMA. 1998;280:1679–84.
- Bradford WZ, Koehler J, El-Hajj H, Hopewell PC, Reingold AL, Agasino CB, Dissemination of Mycobacterium tuberculosis across the San Francisco Bay area. J Infect Dis. 1998;177:1101–7.
- Bifani PJ, Plikaytis BB, Kapur V, Stockbauer K, Pan X, Lutfey ML, Origin and interstate spread of a New York City multidrug-resistant Mycobacterium tuberculosis clone family. JAMA. 1996;275:452–7.
- Casper C, Singh SP, Rane S, Daley CL, Schechter GS, Riley LW, The transcontinental transmission of tuberculosis: a molecular epidemiological assessment. Am J Public Health. 1996;86:551–3.
- Curtis AB, Ridzon R, Novick LF, Driscoll J, Blair D, Oxtoby M, Analysis of Mycobacterium tuberculosis transmission patterns in a homeless shelter outbreak. Int J Tuberc Lung Dis. 2000;4:308–13.
- National Academy of Sciences (NAS). Ending neglect: The elimination of tuberculosis in the United States. Washington: National Academy Press; 2000.
- Nardell E, McInnis B, Thomas B, Weidhaus S. Exogenous reinfection with tuberculosis in a shelter for the homeless. N Engl J Med. 1986;315:1570–5.
- Sonnenberg P, Murray J, Glynn JR, Shearere S, Kambashi B, Godfrey-Faussett P. HIV-1 and recurrence, relapse, and reinfection of tuberculosis after cure: a cohort study in South African mineworkers. Lancet. 2001;358:1687–93.
- Table. Selected characteristics among homeless and nonhomeless clustered tuberculosis case-patients, Maryland and Washington, D.C.a,b
Suggested citation for this article: Lathan M, Mukasa LN, Hooper N, Golub J, Baruch N, Mulcahy D, et al. Cross-Jurisdictional transmission of Mycobacterium tuberculosis in Maryland and Washington, D.D., 1996-2000, linked to the homeless. Emerg Infect Dis [serial online] 2002 Nov [date cited]. Available from http://wwwnc.cdc.gov/eid/article/8/11/02-0245
Please use the form below to submit correspondence to the authors or contact them at the following address:
Wendy A. Cronin, Maryland Department of Health and Mental Hygiene, 201 West Preston St., Room 307A, Baltimore, MD 21201, USA; fax: 410-669-4215;
Comment submitted successfully, thank you for your feedback.
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
- Page created: July 19, 2010
- Page last updated: July 19, 2010
- Page last reviewed: July 19, 2010
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)